NYU/Bellevue Psychopharmacology Annual Review

Course Description

The pharmacological treatment of mental disorders continues to evolve as new drugs emerge and better understanding develops about the risks and benefits of existing therapies. The challenge clinicians who treat patients with psychiatric disorders face is how to use medications most effectively while reducing associated treatment risks. This task is complicated by increasingly frequent FDA safety warnings and studies purporting to find previously unrecognized side effects linked to various drugs and drug classes. This often leads to revision in prescribing practices and greater reluctance on the part of patients to accept treatment recommendations. This annual, one-day course is intended for psychiatrists and neurologists. Other interested physicians, physician assistants, nurses and allied health professionals will also find this course useful and beneficial. The course planners designed this program to provide expert perspectives on the quality and clinical relevance of evolving evidence that should be considered in making decisions about treatment selection and use. Clinical and regulatory concerns will be discussed. There will also be an expert panel discussion of the relative value (if any) of treatment guidelines published by professional associations or adopted by states.

Target Audience

Faculty and trainees in psychiatry and neurology, as well as all other mental health personnel

Saturday, March 4, 2017

NYU Langone Medical Center
550 First Avenue (31st Street)
Alumni Hall, Farkas Auditorium
New York, NY 10016

Course Director

Norman Sussman, MD

Course Brochure

Register Online*

Register Via Fax*

Psychocardiology: Treating Mood Disorders While Minimizing Cardiovascular and Metabolic

Course Description 

The NYU Post-Graduate Medical School, the NYU Langone Medical Center Department of Medicine, Division of Cardiology, and the Department of Psychiatry collaborates to offer this concise half-day CME activity. It is intended to provide an update on new information from epidemiological and clinical trials, as well as drug safety data about the risk factors for and management of cardiovascular disease (CVD) in depressed patients and will provide for ample interaction amongst the faculty and between the audience and the faculty. The general theme will be how to improve treatment outcomes while minimizing risks. 

Target Audience 

All interested psychiatrists and other specialists as well as nurse practitioners and physician assistants

*Please check back for course dates.